Sugiyama A : Sensitive and reliable proarrhythmia in vivo animal models for predicting drug-induced torsades de pointes in patients with remodelled hearts. Br J Pharmacol, 2008 ; 154: 1528~1537
The ICH Steering Committee : The non-clinical evaluation of the potential for delayed ventricular repolarization (QT interval prolongation) by human pharmaceuticals (S7B) . The international conference on harmonisation of technical requirements for registration of pharmaceuticals for human use (ICH) , The Guideline was recommended for adoption at Step 4 of the ICH process in May 2005(http://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Safety/S7B/Step4/S7B_Guideline.pdf) (2014年12月閲覧)
The ICH Steering Committee : The clinical evaluation of QT/QTc interval prolongation and proarrhythmic potential for non-antiarrhythmic drugs (E14) . The international conference on harmonisation of technical requirements for registration of pharmaceuticals for human use (ICH) , The Guideline was recommended for adoption at Step 4 of the ICH process in May 2005 (http://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Efficacy/E14/E14_Guideline.pdf) (2014年12月閲覧)